Oncology Deal-Making The Daiichi Way

$13bn Deal Value In 18 Months

 
• By Ian Haydock
  
Monomethyl auristatin E (MMAE, vedotin), the cytotoxic payload of brentuximab vedotin antibody-drug conjugate. Atoms are represented as spheres with conventional color coding: hydrogen (white), etc
ADC Focus For Daiichi As It Pursues Oncology Goals • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip